‘Rituximab-Induced Inhibition of Antiapoptotic Cell Survival Pathways: Implications in Chemo/Immunoresistance, Rituximab Unresponsiveness, Prognostic and Novel Therapeutic Interventions’

Oncogene - United Kingdom
doi 10.1038/sj.onc.1210365
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

M7‐FLIPI Is Not Prognostic in Follicular Lymphoma Patients With First‐line Rituximab Chemo‐free Therapy

British Journal of Haematology
Hematology
2019English

Rituximab-Induced Coronary Vasospasm

Case Reports in Hematology
2012English

Rituximab-Induced Hypersensitivity Pneumonitis

Respiration
PulmonaryRespiratory Medicine
2009English

Maintenance Rituximab Is Associated With Improved Overall Survival in Mantle Cell Lymphoma Patients Responding to Induction Therapy With Bendamustine + Rituximab (Br)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

The Prognostic Value of Flipi in the Era of Rituximab

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Rituximab-Induced Acute and Delayed Serum Sickness in Thrombotic Thrombocytopenic Purpura: The Role of Anti-Rituximab Antibodies

British Journal of Haematology
Hematology
2018English

Rituximab-Induced Splenic Rupture and Cytokine Release

American Journal of Case Reports
Medicine
2016English

Complement Activation Determines the Therapeutic Activity of Rituximab in Vivo

Journal of Immunology
AllergyImmunology
2003English

Pathology of Rituximab-Induced Kaposi Sarcoma Flare

BMC Clinical Pathology
Forensic MedicinePathologyHistology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy